Threshold Pharmaceuticals, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Threshold Pharmaceuticals, Inc. - overview
Established
2001
Location
Redwood City, CA, US
Primary Industry
Biotechnology
About
Founded in 2001 and based in California, US, Threshold Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of therapeutic medicine for cancer.
Current Investors
CHL Medical Partners, Morgenthaler Ventures, Sofinnova Investments
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Oncology/Cancer Treatment
Website
www.thresholdpharm.com
Company Stage
PIPE
Total Amount Raised
Subscriber access only
Threshold Pharmaceuticals, Inc. - timeline of key events
Threshold Pharmaceuticals, Inc. - financials
| Fiscal Year Ended | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 5,867,000 | 12,495,000 | 14,722,000 | 76,915,000 | - | 3,395,000 | 13,285,000 | 22,270,000 | 18,845,000 | - | - | - |
| % Revenue Growth (YoY) | - | 113.0% | 17.8% | 422.4% | - | - | 291.3% | 67.6% | (15.4%) | - | - | - |
| EBITDA (USD) | (18,991,000) | (24,518,000) | (29,942,000) | 27,930,000 | (23,939,000) | (17,350,000) | 32,291,000 | 72,117,000 | 105,207,000 | - | - | - |
| Operating Income (USD) | (19,999,000) | (26,024,000) | (31,251,000) | 26,928,000 | (24,362,000) | (17,847,000) | 30,999,000 | 70,449,000 | 100,842,000 | - | - | - |
| Operating Margin | (340.9%) | (208.3%) | (212.3%) | 35.0% | - | (525.7%) | 233.3% | 316.3% | 535.1% | - | - | - |
| % EBITDA Margin | (323.7%) | (196.2%) | (203.4%) | 36.3% | - | (511.0%) | 243.1% | 323.8% | 558.3% | - | - | - |
| NET Income (USD) | (71,135,000) | (28,415,000) | (21,584,000) | 43,822,000 | (24,094,000) | (23,140,000) | 30,287,000 | 69,421,000 | 104,916,000 | - | - | - |
| % Net Margin | (1212.5%) | (227.4%) | (146.6%) | 57.0% | - | (681.6%) | 228.0% | 311.7% | 556.7% | - | - | - |
Threshold Pharmaceuticals, Inc. - employee data
Threshold Pharmaceuticals, Inc. - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Member Board Of Directors | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.